Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 studyKohei Shitara, Yung‐Jue Bang, Hisateru Yasui et al.|The Lancet Oncology|2023Cited by 336
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosisYoko Matsuda, Futoshi Suizu, Juanjuan Ye et al.|JNCI Journal of the National Cancer Institute|2022Cited by 18
Phosphorylation of <scp>hTERT</scp> at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organsYoko Matsuda, Kenkichi Masutomi, Taro Yamashita et al.|The Journal of Pathology|2022Cited by 13